Topic: Ebola Virus

The U.S. Air Force's Negatively Pressurized Conex designed to transport people with infectious diseases, like COVID-19, has moved 12 patients, completing its first operational mission.

The COVID-19 outbreak in the U.S. will continue to "get worse before it gets better," but the situation might improve as clinicians gain better understanding of how to treat the virus until there's a vaccine or cure.

A United Nations agency called on authorities in the Democratic Republic of the Congo Tuesday to protect civilians and hold people responsible for a wave of attacks by armed groups.

Chinese officials announced Monday that they have approved a new COVID-19 vaccine for immediate use by military personnel. The vaccine, called Ad5-nCoV, is currently being evaluated in clinical trials.

U.S. drugmaker Gilead Sciences said Monday it will charge $2,340 per treatment for its experimental drug remdesivir, which has been shown to reduce the time needed for a patient to recover from COVID-19.

The World Health Organization said Thursday that the Ebola outbreak in the eastern Democratic Republic of the Congo, which killed 2,280 people over nearly two years, is over.

Gilead Sciences plans to start clinical trials for an inhaled version of the antiviral remdesivir for the treatment of COVID-19, company officials said Monday.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, warned Tuesday that the COVID-19 pandemic is not yet over, describing the quickly spreading virus as his "worst nightmare."

The head of the World Health Organization warned Monday that governments should guard against complacency in the battle against the spread of COVID-19, especially because of public gatherings and protests worldwide.

As the Democratic Republic of the Congo neared declaring over an Ebola outbreak in its eastern provinces, health officials on Monday announced a new cluster has emerged on the other side of the African nation.

For months, the coronavirus pandemic forced hospitals to delay elective surgeries as doctors turned their attention to treating COVID-19 patients, but the spigots on non-urgent procedures are about to reopen.

As the worldwide death toll from the novel coronavirus continues to rise, scientists across the globe are racing to find a vaccine.

U.S. pharmaceutical giant Merck on Tuesday jumped into the race to develop a COVID-19 vaccine, announcing three separate efforts through collaborations and a corporate acquisition.

Up to one in six people declared recovered from COVID-19 and discharged from the hospital still test positive for the virus up to three weeks later, meaning they still might be contagious, according to a study in JAMA.

A new study suggesting that the new coronavirus has mutated to become even more infectious should be viewed with skepticism, multiple experts said Wednesday.